Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Comparison of concurrent chemoradiotherapy versus induction chemotherapy followed by radiation in patients with nasopharyngeal carcinoma.
Komatsu M, Tsukuda M, Matsuda H, Horiuchi C, Taguch T, Takahashi M, Nishimura G, Mori M, Niho T, Ishitoya J, Sakuma Y, Hirama M, Shiono O.
Anticancer Res. 2012 Feb;32(2):681-6.
Related citations
Treatment evaluation of metastatic lymph nodes after concurrent chemoradiotherapy in patients with head and neck squamous cell carcinoma.
Nishimura G, Matsuda H, Taguchi T, Takahashi M, Komatsu M, Sano D, Sakuma N, Arai Y, Takahashi H.
Anticancer Res. 2012 Feb;32(2):595-600.
SCOPE1: a randomised phase II/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesophagus.
Hurt CN, Nixon LS, Griffiths GO, Al-Mokhtar R, Gollins S, Staffurth JN, Phillips CJ, Blazeby JM, Crosby TD.
BMC Cancer. 2011 Oct 28;11:466.
Genome wide single cell analysis of chemotherapy resistant metastatic cells in a case of gastroesophageal adenocarcinoma.
Hjortland GO, Meza-Zepeda LA, Beiske K, Ree AH, Tveito S, Hoifodt H, Bohler PJ, Hole KH, Myklebost O, Fodstad O, Smeland S, Hovig E.
BMC Cancer. 2011 Oct 20;11:455.
Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs.
Gourzones C, Jimenez AS, Busson P.
Cancer. 2012 Feb 1. doi: 10.1002/cncr.26514. [Epub ahead of print] No abstract available.
Reply to profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs.
Wong AM, Tsang JW, Guan XY.
Cancer. 2012 Feb 1. doi: 10.1002/cncr.26513. [Epub ahead of print] No abstract available.
Effects of ghrelin administration during chemotherapy with advanced esophageal cancer patients: A prospective, randomized, placebo-controlled phase 2 study.
Hiura Y, Takiguchi S, Yamamoto K, Takahashi T, Kurokawa Y, Yamasaki M, Nakajima K, Miyata H, Fujiwara Y, Mori M, Kangawa K, Doki Y.
Cancer. 2012 Jan 26. doi: 10.1002/cncr.27430. [Epub ahead of print]
Exploring biomarkers in head and neck cancer.
Langer CJ.
Cancer. 2012 Jan 26. doi: 10.1002/cncr.26718. [Epub ahead of print]
Effective treatment of metastatic forms of Epstein-Barr virus-associated nasopharyngeal carcinoma with a novel adenovirus-based adoptive immunotherapy.
Smith C, Tsang J, Beagley L, Chua D, Lee V, Li V, Moss DJ, Coman W, Chan KH, Nicholls J, Kwong D, Khanna R.
Cancer Res. 2012 Mar 1;72(5):1116-25. Epub 2012 Jan 26.
Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity, and prognostic discrimination.
Schache AG, Liloglou T, Risk JM, Filia A, Jones TM, Sheard J, Woolgar JA, Helliwell TR, Triantafyllou A, Robinson M, Sloan P, Harvey-Woodworth C, Sisson D, Shaw RJ.
Clin Cancer Res. 2011 Oct 1;17(19):6262-71.
Influence of socioeconomic environment on survival in patients diagnosed with esophageal cancer: a population-based study.
Launay L, Dejardin O, Pornet C, Morlais F, Guittet L, Launoy G, Bouvier V.
Dis Esophagus. 2012 Jan 31. doi: 10.1111/j.1442-2050.2011.01312.x. [Epub ahead of print]
Immunohistochemical study of nuclear factor-κB expression in esophageal squamous cell carcinoma: prognostic significance and sensitivity to treatment with 5-FU.
Hatata T, Higaki K, Tatebe S, Shomori K, Ikeguchi M.
Dis Esophagus. 2012 Jan 31. doi: 10.1111/j.1442-2050.2011.01308.x. [Epub ahead of print]
Probe-based confocal endomicroscopy in Barrett's esophagus: the real deal or another tease?
Falk GW.
Gastrointest Endosc. 2011 Sep;74(3):473-6. No abstract available.
Real-time increased detection of neoplastic tissue in Barrett's esophagus with probe-based confocal laser endomicroscopy: final results of an international multicenter, prospective, randomized, controlled trial.
Sharma P, Meining AR, Coron E, Lightdale CJ, Wolfsen HC, Bansal A, Bajbouj M, Galmiche JP, Abrams JA, Rastogi A, Gupta N, Michalek JE, Lauwers GY, Wallace MB.
Gastrointest Endosc. 2011 Sep;74(3):465-72. Epub 2011 Jul 13.
Endoscopy for upper GI cancer screening in the general population: a cost-utility analysis.
Gupta N, Bansal A, Wani SB, Gaddam S, Rastogi A, Sharma P.
Gastrointest Endosc. 2011 Sep;74(3):610-624.e2. Epub 2011 Jul 13.
Long-term outcome of transoral organ-preserving pharyngeal endoscopic resection for superficial pharyngeal cancer.
Muto M, Satake H, Yano T, Minashi K, Hayashi R, Fujii S, Ochiai A, Ohtsu A, Morita S, Horimatsu T, Ezoe Y, Miyamoto S, Asato R, Tateya I, Yoshizawa A, Chiba T.
Gastrointest Endosc. 2011 Sep;74(3):477-84. Epub 2011 Jun 25.
A new fully covered metal stent for the treatment of benign and malignant dysphagia: a prospective follow-up study.
Hirdes MM, Siersema PD, Vleggaar FP.
Gastrointest Endosc. 2012 Apr;75(4):712-8. Epub 2012 Jan 28.
Salivary protein and solCD44 levels as a potential screening tool for early detection of head and neck squamous cell carcinoma.
Franzmann EJ, Reategui EP, Pereira LH, Pedroso F, Joseph D, Allen GO, Hamilton K, Reis I, Duncan R, Goodwin WJ, Hu JJ, Lokeshwar VB.
Head Neck. 2012 May;34(5):687-95. doi: 10.1002/hed.21810. Epub 2011 Jul 11.
Assessment of second tier lymph nodes in melanoma and implications for extent of elective neck dissection in metastatic cutaneous malignancy of the parotid.
Ch'ng S, Pinna A, Ioannou K, Juszczyk K, Shannon K, Clifford A, Uren R, Clark JR.
Head Neck. 2012 Jan 31. doi: 10.1002/hed.22948. [Epub ahead of print]
Value of narrow band imaging endoscopy in early mucosal head and neck cancer.
Lin YC, Wang WH, Lee KF, Tsai WC, Weng HH.
Head Neck. 2012 Jan 31. doi: 10.1002/hed.21964. [Epub ahead of print]
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on